Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECLIPSE-SNP: Clevidipine vs Sodium Nitroprusside for Perioperative Hypertension
NCT00093912Phase 3Completed
- Sponsor
- The Medicines Company
- Start
- Jun 2004
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of clevidipine in hypertension (HTN) (2 arms), sponsored by The Medicines Company. Primary endpoint: Incidence of death, stroke, myocardial infarction (MI) and renal dysfunction at Day 30. Started Jun 2004; status: completed.
02
Drugs
clevidipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00093912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00093912.